The therapeutic potential of cystathionine β-Synthetase/hydrogen sulfide inhibition in cancer

Antioxidants and Redox Signaling

Volumn 22, Issue 5, 2015, Pages 424-448

  Hellmich, Mark R ^a   Coletta, Ciro ^a   Chao, Celia ^a   Szabo, Csaba ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOOXYACETIC ACID; CYSTATHIONINE BETA SYNTHASE; ENZYME INHIBITOR; HYDROGEN SULFIDE; ANTINEOPLASTIC AGENT;

BIOLOGICAL ACTIVITY; BIOSYNTHESIS; CANCER CELL CULTURE; CANCER INHIBITION; CANCER THERAPY; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CANCER; ENZYME INHIBITION; ENZYMOLOGY; HUMAN; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; CHEMISTRY; COLORECTAL NEOPLASMS; DRUG EFFECTS; ENERGY METABOLISM; FEMALE; METABOLISM; OVARIAN NEOPLASMS;

AMINOOXYACETIC ACID; ANIMALS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYSTATHIONINE BETA-SYNTHASE; ENERGY METABOLISM; FEMALE; HUMANS; HYDROGEN SULFIDE; OVARIAN NEOPLASMS;

EID: 84921911299     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.5933     Document Type: Review

References (149)

1. Abe K and Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16: 1066-1071, 1996.
2. Abraham JM and Cho L. The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease? Cleve Clin J Med 77: 911-918, 2010.
3. Akahoshi N, Kobayashi C, Ishizaki Y, Izumi T, Himi T, Suematsu M, and Ishii I. Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. Hum Mol Genet 17: 1994-2005, 2008.
4. Altomare DF, Di Lena M, Porcelli F, Trizio L, Travaglio E, Tutino M, Dragonieri S, Memeo V, and de Gennaro G. Exhaled volatile organic compounds identify patients with colorectal cancer. Br J Surg 100: 144-150, 2013.
5. Asimakopoulou A, Panopoulos P, Chasapis CT, Coletta C, Zhou Z, Cirino G, Giannis A, Szabo C, Spyroulias GA, and Papapetropoulos A. Selectivity of commonly used pharmacological inhibitors for cystathionine b synthase (CBS) and cystathionine c lyase (CSE). Br J Pharmacol 169: 922-932, 2013.
6. Attene-Ramos MS, Wagner ED, Plewa MJ, and Gaskins HR. Evidence that hydrogen sulfide is a genotoxic agent. Mol Cancer Res 4: 9-14, 2006.
7. Banerjee R, Evande R, Kabil O, Ojha S, and Taoka S. Reaction mechanism and regulation of cystathionine betasynthase. Biochim Biophys Acta 1647: 30-35, 2003.
8. Baskar R and Bian J. Hydrogen sulfide gas has cell growth regulatory role. Eur J Pharmacol 656: 5-9, 2011.
9. Benavides GA, Squadrito GL, Mills RW, Patel HD, Isbell TS, Patel RP, Darley-Usmar VM, Doeller JE, and Kraus DW. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci U S A 104: 17977-17982, 2007.
10. Bhattacharyya S, Saha S, Giri K, Lanza IR, Nair KS, Jennings NB, Rodriguez-Aguayo C, Lopez-Berestein G, Basal E, Weaver AL, Visscher DW, Cliby W, Sood AK, Bhattacharya R, and Mukherjee P. Cystathionine betasynthase (CBS) contributes to advanced ovarian cancer progression and drug resistance. PLoS One 8:-79167, 2013.
11. Bir SC, Kolluru GK, McCarthy P, Shen X, Pardue S, Pattillo CB, and Kevil CG. Hydrogen sulfide stimulates ischemic vascular remodeling through nitric oxide synthase and nitrite reduction activity regulating hypoxiainducible factor-1a and vascular endothelial growth factor-dependent angiogenesis. J Am Heart Assoc 1:-004093, 2012.
12. Boushey CJ, Beresford SA, Omenn GS, and Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 274: 1049-1057, 1995.
13. Cai WJ, Wang MJ, Ju LH, Wang C, and Zhu YC. Hydrogen sulfide induces human colon cancer cell proliferation: role of Akt, ERK and p21. Cell Biol Int 34: 565-572, 2010.
14. Cai WJ, Wang MJ, Moore PK, Jin HM, Yao T, and Zhu YC. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 76: 29-40, 2007.
15. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, and Lefer DJ. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 105: 365-374, 2009.
16. Chao C, Bohannon FJ, Mrazek A, Coletta C, Szabo C, Hellmich MR. Cysthionine-b-synthetase inhibition in combination with standard-chemotherapy decreases colorectal cancer metastasis to the liver. Nitric Oxide 39: S21, 2014.
17. Carballal S, Cuevasanta E, Marmisolle I, Kabil O, Gherasim C, Ballou DP, Banerjee R, and Alvarez B. Kinetics of reversible reductive carbonylation of heme in human cystathionine b-synthase. Biochemistry 52: 4553-4562, 2013.
18. Chattopadhyay M, Nath N, Kodela R, Sobocki T, Metkar S, Gan ZY, and Kashfi K. Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates b-catenin expression. Leuk Res 37: 1302-1308, 2013.
19. Chong CR and Sullivan DJ, Jr. New uses for old drugs. Nature 448: 645-646, 2007.
20. Chwatko G, Forma E, Wilkosz J, Gowacki R, Jóźwiak P, Ró-zański W, Brys̈ M, and Krzes̈lak A. Thiosulfate in urine as a facilitator in the diagnosis of prostate cancer for patients with prostate-specific antigen less or equal 10 ng/mL. Clin Chem Lab Med 51: 1825-1831, 2013.
21. Coletta C, Papapetropoulos A, Erdelyi K, Olah G, Módis K, Panopoulos P, Asimakopoulou A, Gerö D, Sharina I, Martin E, and Szabo C. Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci U S A 109: 9161-9166, 2012.
22. D'Amico A, Di Natale C, Falconi C, Martinelli E, Paolesse R, Pennazza G, Santonico M, and Sterk PJ. U-BIOPRED study. Detection and identification of cancers by the electronic nose. Expert Opin Med Diagn 6: 175-185, 2012.
23. Dang CV, Hamaker M, Sun P, Le A, and Gao P. Therapeutic targeting of cancer cell metabolism. J Mol Med (Berl) 89: 205-212, 2011.
24. De Vos J, Thykjaer T, Tarte K, Ensslen M, Raynaud P, Requirand G, Pellet F, Pantesco V, Réme T, Jourdan M, Rossi JF, Orntoft T, and Klein B. Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays. Oncogene 21: 6848-6857, 2002.
25. Den Heijer M, Lewington S, and Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 3: 292-299, 2005.
26. Deplancke B and Gaskins HR. Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells. FASEB J 17: 1310-1312, 2003.
27. Doeller JE, Isbell TS, Benavides G, Koenitzer J, Patel H, Patel RP, Lancaster JR, Jr., Darley-Usmar VM, and Kraus DW. Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues. Anal Biochem 341: 40-51, 2005.
28. Duell PB and Malinow MR. Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol 8: 28-34, 1997.
29. Ereño-Orbea J, Majtan T, Oyenarte I, Kraus JP, and Martńez-Cruz LA. Structural basis of regulation and oligomerization of human cystathionine b-synthase, the central enzyme of transsulfuration. Proc Natl Acad Sci U S A 110: E3790-E3799, 2013.
30. Fiorucci S, Distrutti E, Cirino G, and Wallace JL. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology 131: 259-271, 2006.
31. Frantzias J, Logan JG, Mollat P, Sparatore A, Del Soldato P, Ralston SH, and Idris AI. Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo. Br J Pharmacol 165: 1914-1925, 2012.
32. Fu M, Zhang W, Wu L, Yang G, Li H, and Wang R. Hydrogen sulfide (H2S) metabolism in mitochondria and its regulatory role in energy production. Proc Natl Acad Sci U S A 109: 2943-2948, 2012.
33. Ge Y, Jensen TL, Matherly LH, and Taub JW. Synergistic regulation of human cystathionine-beta-synthase-1b promoter by transcription factors NF-YA isoforms and Sp1. Biochim Biophys Acta 1579: 73-80, 2002.
34. Geiser CF and Efron ML. Cystathioninuria in patients with neuroblastoma or ganglioneuroblastoma. Its correlation to vanilmandelic acid excretion and its value in diagnosis and therapy. Cancer 22: 856-860, 1968.
35. Geiser CF and Shih VE. Cystathioninuria and its origin in children with hepatoblastoma. J Pediatr 96: 72-75, 1980.
36. Gjessing LR. Cystathioninuria and vanil-lactic-aciduria in neuroblastoma and argentaffinoma. Lancet 2: 1281-1282, 1963.
37. Goubern M, Andriamihaja M, Nübel T, Blachier F, and Bouillaud F. Sulfide, the first inorganic substrate for human cells. FASEB J 21: 1699-1706, 2007.
38. Greenhouse WV and Lehninger AL. Magnitude of malateaspartate reduced nicotinamide adenine dinucleotide shuttle activity in intact respiring tumor cells. Cancer Res 37: 4173-4181, 1977.
39. Greiner R, Pálinkás Z, Bäsell K, Becher D, Antelmann H, Nagy P, and Dick TP. Polysulfides link H2S to protein thiol oxidation. Antioxid Redox Signal 19: 1749-1765, 2013.
40. Guo H, Gai JW, Wang Y, Jin HF, Du JB, and Jin J. Characterization of hydrogen sulfide and its synthases, cystathionine b-synthase and cystathionine c-lyase, in human prostatic tissue and cells. Urology 79: 483, 2012.
41. Gupta S, Kühnisch J, Mustafa A, Lhotak S, Schlachterman A, Slifker MJ, Klein-Szanto A, High KA, Austin RC, and Kruger WD. Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia. FASEB J 23: 883-893, 2009.
42. Gupta S, Wang L, Anderl J, Slifker MJ, Kirk C, and Kruger WD. Correction of cystathionine b-synthase deficiency in mice by treatment with proteasome inhibitors. Hum Mutat 34: 1085-1093, 2013.
43. Guth PS, Risey J, Briner W, Blair P, Reed HT, Bryant G, Norris C, Housley G, and Miller R. Evaluation of aminooxyacetic acid as a palliative in tinnitus. Ann Otol Rhinol Laryngol 99: 74-79, 1990.
44. Hansel DE, Rahman A, Hidalgo M, Thuluvath PJ, Lillemoe KD, Shulick R, Ku JL, Park JG, Miyazaki K, Ashfaq R, Wistuba II, Varma R, Hawthorne L, Geradts J, Argani P, and Maitra A. Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol 163: 217-229, 2003.
45. This reference has been deleted.
46. Holwerda KM, Burke SD, Faas MM, Zsengeller Z, Stillman IE, Kang PM, van Goor H, McCurley A, Jaffe IZ, Karumanchi SA, and Lely AT. Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor. J Am Soc Nephrol 25: 717-725, 2014.
47. Horvath G, Andersson H, and Nemes S. Cancer odor in the blood of ovarian cancer patients: a retrospective study of detection by dogs during treatment, 3 and 6 months afterward. BMC Cancer 13: 396, 2013.
48. Huang J, Kumar S, Abbassi-Ghadi N, Spane?l P, Smith D, and Hanna GB. Selected ion flow tube mass spectrometry analysis of volatile metabolites in urine headspace for the profiling of gastro-esophageal cancer. Anal Chem 85: 3409-3416, 2013.
49. Huang Y, Li F, Tong W, Zhang A, He Y, Fu T, and Liu B. Hydrogen sulfide, a gaseous transmitter, stimulates proliferation of interstitial cells of Cajal via phosphorylation of AKT protein kinase. Tohoku J Exp Med 221: 125-132, 2010.
50. Ishii I, Akahoshi N, Yamada H, Nakano S, Izumi T, and Suematsu M. Cystathionine gamma-lyase-deficient mice require dietary cysteine to protect against acute lethal myopathy and oxidative injury J Biol Chem 285: 26358-26368, 2010.
51. Jacobsen DW, Catanescu O, Dibello PM, and Barbato JC. Molecular targeting by homocysteine: a mechanism for vascular pathogenesis. Clin Chem Lab Med 43: 1076-1083, 2005.
52. Jhee KH and Kruger WD. The role of cystathionine betasynthase in homocysteine metabolism. Antioxid Redox Signal 7: 813-822, 2005.
53. Jones KM, Liao E, Hohneker K, Turpin S, Henry MM, Selinger K, Hsyu PH, Boucher RC, Knowles MR, and Dukes GE. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis. Pharmacotherapy 17: 263-270, 1997.
54. Jorga KM, Larsen JP, Beiske A, Schleimer M, Fotteler B, Schmitt M, and Moe B. The effect of tolcapone on the pharmacokinetics of benserazide. Eur J Neurol 6: 211-219, 1999.
55. Kabil O and Banerjee R. Enzymology of H2S biogenesis, decay and signaling. Antioxid Redox Signal 20: 770-782, 2014.
56. Kabil O, Zhou Y, and Banerjee R. Human cystathionine beta-synthase is a target for sumoylation. Biochemistry 45: 13528-13536, 2006.
57. Kajimura M, Nakanishi T, Takenouchi T, Morikawa T, Hishiki T, Yukutake Y, and Suematsu M. Gas biology: tiny molecules controlling metabolic systems. Respir Physiol Neurobiol 184: 139-148, 2012.
58. Kashfi K. Anti-cancer activity of new designer hydrogen sulfide-donating hybrids. Antioxid Redox Signal 20: 831-846, 2014.
59. Kery V, Poneleit L, and Kraus JP. Trypsin cleavage of human cystathionine beta-synthase into an evolutionarily conserved active core: structural and functional consequences. Arch Biochem Biophys 355: 222-232, 1998.
60. Kimura H. Hydrogen sulfide: its production, release and functions. Amino Acids 41: 113-121, 2011.
61. Kimura H. The physiological role of hydrogen sulfide and beyond. Nitric Oxide 2014 [Epub ahead of print]; DOI: 10.1016/j.niox.2014.01.002.
62. Kimura Y, Mikami Y, Osumi K, Tsugane M, Oka J, and Kimura H. Polysulfides are possible H2S-derived signaling molecules in rat brain. FASEB J 27: 2451-2457, 2013.
63. Klein CE, Roberts B, Holcenberg J, and Glode LM. Cystathionine metabolism in neuroblastoma. Cancer 62: 291-298, 1988.
64. Kodela R, Chattopadhyay M, and Kashfi K. Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential. Med Chem Comm 4: 1039, 2013.
65. Koike S, Ogasawara Y, Shibuya N, Kimura H, and Ishii K. Polysulfide exerts a protective effect against cytotoxicity caused by t-buthylhydroperoxide through Nrf2 signaling in neuroblastoma cells. FEBS Lett 587: 3548-3555, 2013.
66. Krishnan N, Fu C, Pappin DJ, and Tonks NK. H2SInduced sulfhydration of the phosphatase PTP1B and its role in the endoplasmic reticulum stress response. Sci Signal 4: ra86, 2011.
67. Kumar S, Huang J, Cushnir JR, S ? pane?l P, Smith D, and Hanna GB. Selected ion flow tube-MS analysis of headspace vapor from gastric content for the diagnosis of gastroesophageal cancer. Anal Chem 84: 9550-9557, 2012.
68. Lagoutte E, Mimoun S, Andriamihaja M, Chaumontet C, Blachier F, and Bouillaud F. Oxidation of hydrogen sulfide remains a priority in mammalian cells and causes reverse electron transfer in colonocytes. Biochim Biophys Acta 1797: 1500-1511, 2010.
69. Lee ZW, Zhou J, Chen CS, Zhao Y, Tan CH, Li L, Moore PK, and Deng LW. The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PLoS One 6:-21077, 2011.
70. Lentz SR, Erger RA, Dayal S, Maeda N, Malinow MR, Heistad DD, and Faraci FM. Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice. Am J Physiol Heart Circ Physiol 279: H970-H975, 2000.
71. Leunis N, Boumans ML, Kremer B, Din S, Stobberingh E, Kessels AG, and Kross KW. Application of an electronic nose in the diagnosis of head and neck cancer. Laryngoscope 2014 [Epub ahead of print]; DOI: doi: 10.1002/lary.24463.
72. Lin VS, Lippert AR, and Chang CJ. Cell-trappable fluorescent probes for endogenous hydrogen sulfide signaling and imaging H2O2-dependent H2S production. Proc Natl Acad Sci U S A 110: 7131-7135, 2013.
73. Ma K, Liu Y, Zhu Q, Liu CH, Duan JL, Tan BK, and Zhu YZ. H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S? PLoS One 6:-20525, 2011.
74. Maclean KN, Kraus E, and Kraus JP. The dominant role of Sp1 in regulating the cystathionine beta-synthase-1a and-1b promoters facilitates potential tissue-specific regulation by Kruppel-like factors. J Biol Chem 279: 8558-8566, 2004.
75. Maclean KN, Sikora J, Ko-zich V, Jiang H, Greiner LS, Kraus E, Krijt J, Crnic LS, Allen RH, Stabler SP, Elleder M, and Kraus JP. Cystathionine beta-synthase null homocystinuric mice fail to exhibit altered hemostasis or lowering of plasma homocysteine in response to betaine treatment. Mol Genet Metab 101: 163-171, 2010.
76. Manna P and Jain SK. Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase (AKT)/protein kinase Cf/k (PKCf/k) in 3T3l1 adipocytes. J Biol Chem 286: 39848-39859, 2011.
77. Meier M, Oliveriusova J, Kraus JP, and Burkhard P. Structural insights into mutations of cystathionine betasynthase. Biochim Biophys Acta 1647: 206-213, 2003.
78. Miles EW and Kraus JP. Cystathionine beta-synthase: structure, function, regulation, and location of homocystinuria-causing mutations. J Biol Chem 279: 29871-29874, 2004.
79. Módis K, Bos EM, Calzia E, van Goor H, Coletta C, Papapetropoulos A, Hellmich MR, Radermacher P, Bouillaud F, and Szabo C. Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects. Br J Pharmacol 171: 2123-2146, 2014.
80. Módis K, Coletta C, Asimakopoulou A, Szczesny B, Chao C, Papapetropoulos A, Hellmich MR, and Szabo C. Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-b-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro. Nitric Oxide 2014 [Epub ahead of print]; DOI: 10.1016/j.niox.2014.03.001.
81. Módis K, Coletta C, Erdélyi K, Papapetropoulos A, and Szabo C. Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics. FASEB J 27: 601-611, 2013.
82. Módis K, Panopoulos P, Coletta C, Papapetropoulos A, and Szabo C. Hydrogen sulfide-mediated stimulation of mitochondrial electron transport involves inhibition of the mitochondrial phosphodiesterase 2A, elevation of cAMP and activation of protein kinase A. Biochem Pharmacol 86: 1311-1319, 2013.
83. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GH, Bromberg IL, Cerone R, Fowler B, Grobe H, Schmidt H, and Schweitzer L. The natural history of homocystinuria due to cystathionine betasynthase deficiency. Am J Hum Genet 37: 1-31, 1985.
84. Murata T, Sato T, Kamoda T, Moriyama H, Kumazawa Y, and Hanada N. Differential susceptibility to hydrogen sulfide-induced apoptosis between PHLDA1-overexpressing oral cancer cell lines and oral keratinocytes: Role of PHLDA1 as an apoptosis suppressor. Exp Cell Res 320: 247-257, 2014.
85. Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, Gazi SK, Barrow RK, Yang G,Wang R, and Snyder SH. H2S signals through protein S-sulfhydration. Sci Signal 2: ra72, 2009.
86. Muthuramu I, Jacobs F, Singh N, Gordts SC, and De Geest B. Selective homocysteine lowering gene transfer improves infarct healing, attenuates remodelling, and enhances diastolic function after myocardial infarction in mice. PLoS One 8:-63710, 2013.
87. Narayan RK. A technique for C-banding chromosomes with pinacyanol chloride. Stain Technol 55: 9-11, 1980.
88. Nicholls P. Inhibition of cytochrome c oxidase by sulphide. Biochem Soc Trans 3: 316-319, 1975.
89. Nursalim A, Siregar P, and Widyahening IS. Effect of folic acid, vitamin B6 and vitamin B12 supplementation on mortality and cardiovascular complication among patients with chronic kidney disease: an evidence-based case report. Acta Med Indones 45: 150-156, 2013.
90. Olson KR. Is hydrogen sulfide a circulating "gasotransmitter" in vertebrate blood? Biochim Biophys Acta 1787: 856-863, 2009.
91. Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z, Jeschke MG, Branski LK, Herndon DN, Wang R, and Szabo C. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci U S A 106: 21972-21977, 2009.
92. Perry TL and Hansen S. Biochemical effects in man and rat of three drugs which can increase brain GABA content. J Neurochem 30: 679-684, 1978.
93. Perry TL, Wright JM, Hansen S, Allan BM, Baird PA, and MacLeod PM. Failure of aminooxyacetic acid therapy in Huntington disease. Neurology 30: 772-775, 1980.
94. Pun PB, Lu J, Kan EM, and Moochhala S. Gases in the mitochondria. Mitochondrion 10: 83-93, 2010.
95. Pupo E, Pla AF, Avanzato D, Moccia F, Cruz JE, Tanzi F, Merlino A, Mancardi D, and Munaron L. Hydrogen sulfide promotes calcium signals and migration in tumorderived endothelial cells. Free Radic Biol Med 51: 1765-1773, 2011.
96. Puranik M, Weeks CL, Lahaye D, Kabil O, Taoka S, Nielsen SB, Groves JT, Banerjee R, and Spiro TG. Dynamics of carbon monoxide binding to cystathionine betasynthase. J Biol Chem 281: 13433-13438, 2006.
97. Qi F, Zhou Y, Xiao Y, Tao J, Gu J, Jiang X, and Xu GY. Promoter demethylation of cystathionine-b-synthetase gene contributes to inflammatory pain in rats. Pain 154: 34-45, 2013.
98. Qipshidze N, Metreveli N, Mishra PK, Lominadze D, and Tyagi SC. Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis. Int J Biol Sci 8: 430-441, 2012.
99. Ramasamy S, Singh S, Taniere P, Langman MJ, and Eggo MC. Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. Am J Physiol Gastrointest Liver Physiol 291: G288-G296, 2006.
100. Ratnam S, Maclean KN, Jacobs RL, Brosnan ME, Kraus JP, and Brosnan JT. Hormonal regulation of cystathionine beta-synthase expression in liver. J Biol Chem 277: 42912-42918, 2002.
101. Régnier V, Billard JM, Gupta S, Potier B, Woerner S, Paly E, Ledru A, David S, Luilier S, Bizot JC, Vacano G, Kraus JP, Patterson D, Kruger WD, Delabar JM, and London J. Brain phenotype of transgenic mice overexpressing cystathionine b-synthase. PLoS One 7:-29056, 2012.
102. Sabaté R and Estelrich J. Pinacyanol as effective probe of fibrillar beta-amyloid peptide: comparative study with Congo Red. Biopolymers 72: 455-463, 2003.
103. Samudio I, Fiegl M, and Andreeff M. Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. Cancer Res 69: 2163-2166, 2009.
104. Sen N, Paul BD, Gadalla MM, Mustafa AK, Sen T, Xu R, Kim S, and Snyder SH. Hydrogen sulfide-linked sulfhydration of NF-jB mediates its antiapoptotic actions. Mol Cell 45: 13-24, 2012.
105. Sen U, Sathnur PB, Kundu S, Givvimani S, Coley DM, Mishra PK, Qipshidze N, Tyagi N, Metreveli N, and Tyagi SC. Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia. Am J Physiol Cell Physiol 303: C41-C51, 2012.
106. Shen W. Development of a new assay and inhibitors for human cystathionine beta-synthase. Asymmetric catalyst development guided by in situ enzymatic screening. PhD dissertation, University of Nebraska, 2007.
107. Singh LR, Gupta S, Honig NH, Kraus JP, and Kruger WD. Activation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70. PLoS Genet 6:-1000807, 2010.
108. Singh S and Banerjee R. PLP-dependent H2S biogenesis. Biochim Biophys Acta 1814: 1518-1527, 2011.
109. Singh S, Padovani D, Leslie RA, Chiku T, and Banerjee R. Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative transsulfuration reactions. J Biol Chem 284: 22457-22466, 2009.
110. Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, Perera RM, Ferrone CR, Mullarky E, Shyh-Chang N, Kang Y, Fleming JB, Bardeesy N, Asara JM, Haigis MC, DePinho RA, Cantley LC, and Kimmelman AC. Glutamine supports pancreatic cancer growth through a KRASregulated metabolic pathway. Nature 496: 101-105, 2013.
111. Sonoda H, Kohnoe S, Yamazato T, Satoh Y, Morizono G, ShikataK,MoritaM,WatanabeA,MoritaM,KakejiY, Inoue F, and Maehara Y. Colorectal cancer screening with odour material by canine scent detection. Gut 60: 814-819, 2011.
112. Stabler S, Koyama T, Zhao Z, Martinez-Ferrer M, Allen RH, Luka Z, Loukachevitch LV, Clark PE, Wagner C, and Bhowmick NA. Serum methionine metabolites are risk factors for metastatic prostate cancer progression. PLoS One 6:-22486, 2011.
113. Su Y, Majtan T, Freeman KM, Linck R, Ponter S, Kraus JP, and Burstyn JN. Comparative study of enzyme activity and heme reactivity in Drosophila melanogaster and Homo sapiens cystathionine b-synthases. Biochemistry 52: 741-751, 2013.
114. Suzuki K, Olah G, Modis K, Coletta C, Kulp G, Gero D, Szoleczky P, Chang T, Zhou Z, Wu L, Wang R, Papapetropoulos A, and Szabo C. Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci U S A 108: 13829-13834, 2011.
115. Szabo C. Gaseotransmitters: new frontiers for translational science. Sci Transl Med 2: 59ps54, 2010.
116. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6: 917-935, 2007.
117. Szabo C. Medicinal chemistry and therapeutic applications of the gasotransmitters nitric oxide, carbon monoxide and hydrogen sulfide. Burgers Med Chem 5: 265-367, 2010.
118. Szabo C, Coletta C, Chao C, Módis K, Szczesny B, Papapetropoulos A, and Hellmich MR. Tumor-derived hydrogen sulfide, produced by cystathionine-b-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. Proc Natl Acad Sci U S A 110: 12474-12479, 2013.
119. Szabo C and Hellmich MR. Endogenously produced hydrogen sulfide supports tumor cell growth and proliferation. Cell Cycle 12: 2915-2916, 2013.
120. Szabo C and Papapetropoulos A. Hydrogen sulphide and angiogenesis: mechanisms and applications. Br J Pharmacol 164: 853-865, 2011.
121. Szabo C, Ransy C, Módis K, Andriamihaja M, Murghes B, Coletta C, Olah G, Yanagi K, and Bouillaud F. Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms. Br J Pharmacol 171: 2099-2122, 2014.
122. Talaei F, Bouma HR, Van der Graaf AC, Strijkstra AM, Schmidt M, and Henning RH. Serotonin and dopamine protect from hypothermia/rewarming damage through the CBS/H2S pathway. PLoS One 6:-22568, 2011.
123. Tao BB, Liu SY, Zhang CC, Fu W, Cai WJ, Wang Y, Shen Q, Wang MJ, Chen Y, Zhang LJ, Zhu YZ, and Zhu YC. VEGFR2 functions as an H2S-targeting receptor protein kinase with its novel Cys1045-Cys1024 disulfide bond serving as a specific molecular switch for hydrogen sulfide actions in vascular endothelial cells. Antioxid Redox Signal 19: 448-464, 2013.
124. Teng H, Wu B, Zhao K, Yang G, Wu L, and Wang R. Oxygen-sensitive mitochondrial accumulation of cystathionine b-synthase mediated by Lon protease. Proc Natl Acad Sci U S A 110: 12679-12684, 2013.
125. Thornburg JM, Nelson KK, Clem BF, Lane AN, Arumugam S, Simmons A, Eaton JW, Telang S, and Chesney J. Targeting aspartate aminotransferase in breast cancer. Breast Cancer Res 10: R84, 2008.
126. Thorson MK, Majtan T, Kraus JP, and Barrios AM. Identification of cystathionine b-synthase inhibitors using a hydrogen sulfide selective probe. Angew Chem Int Ed Engl 52: 4641-4644, 2013.
127. Tyagi N, Qipshidze N, Sen U, Rodriguez W, Ovechkin A, and Tyagi SC. Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia. Int J Physiol Pathophysiol Pharmacol 3: 210-222, 2011.
128. Vitvitsky V, Prudova A, Stabler S, Dayal S, Lentz SR, and Banerjee R. Testosterone regulation of renal cystathionine beta-synthase: implications for sex-dependent differences in plasma homocysteine levels. Am J Physiol Renal Physiol 293: F594-F600, 2007.
129. Vou͗e PA, Jr., and Wadman SK. Cystathioninuria in hepatoblastoma. Clin Chim Acta 22: 373-378, 1968.
130. Wang L, Jhee KH, Hua X, DiBello PM, Jacobsen DW, and Kruger WD. Modulation of cystathionine beta-synthase level regulates total serum homocysteine in mice. Circ Res 94: 1318-1324, 2004.
131. Wang MJ, Cai WJ, Li N, Ding YJ, Chen Y, and Zhu YC. The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia. Antioxid Redox Signal 12: 1065-1077, 2010.
132. Wang MJ, Cai WJ, and Zhu YC. Mechanisms of angiogenesis: role of hydrogen sulphide. Clin Exp Pharmacol Physiol 37: 764-771, 2010.
133. Wang R. Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev 92: 791-896, 2012.
134. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Budinger GR, and Chandel NS. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A 107: 8788-8793, 2010.
135. Wen S, Zhu D, and Huang P. Targeting cancer cell mitochondria as a therapeutic approach. Future Med Chem 5: 53-67, 2013.
136. Wen YD, Wang H, Kho SH, Rinkiko S, Sheng X, Shen HM, and Zhu YZ. Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress. PLoS One 8:-53147, 2013.
137. Whiteman M, Li L, Rose P, Tan CH, Parkinson DB, and Moore PK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators inmacrophages. Antioxid Redox Signal 12: 1147-1154, 2010.
138. Willis CM, Church SM, and Guest CM. Olfactory detection of human bladder cancer by dogs: proof of principle study. BMJ 329: 712-714, 2004.
139. Wintner EA, Deckwerth TL, Langston W, Bengtsson A, Leviten D, Hill P, Insko MA, Dumpit R, VandenEkart E, Toombs CF, and Szabo C. A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood. Br J Pharmacol 160: 941-957, 2010.
140. Wu YC, Wang XJ, Yu L, Chan FK, Cheng AS, Yu J, Sung JJ, Wu WK, and Cho CH. Hydrogen sulfide lowers proliferation and induces protective autophagy in colon epithelial cells. PLoS One 7:-37572, 2012.
141. Yamagishi K, Onuma K, Chiba Y, Yagi S, Aoki S, Sato T, Sugawara Y, Hosoya N, Saeki Y, Takahashi M, Fuji M, Ohsaka T, Okajima T, Akita K, Suzuki T, Senawongse P, Urushiyama A, Kawai K, Shoun H, Ishii Y, Ishikawa H, Sugiyama S, Nakajima M, Tsuboi M, and Yamanaka T. Generation of gaseous sulfur-containing compounds in tumor tissue and suppression of gas diffusion as an antitumour treatment. Gut 61: 554-561, 2012.
142. Yamanishi M, Kabil O, Sen S, and Banerjee R. Structural insights into pathogenic mutations in heme-dependent cystathionine-beta-synthase. J Inorg Biochem 100: 1988-1995, 2006.
143. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, and Wang R. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322: 587-590, 2008.
144. Yang G, Zhao K, Ju Y, Mani S, Cao Q, Puukila S, Khaper N, Wu L, and Wang R. Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. Antioxid Redox Signal 18: 1906-1919, 2013.
145. Yin P, Zhao C, Li Z, Mei C, Yao W, Liu Y, Li N, Qi J, Wang L, Shi Y, Qiu S, Fan J, and Zha X. Sp1 is involved in regulation of cystathionine c-lyase gene expression and biological function by PI3K/Akt pathway in human hepatocellular carcinoma cell lines. Cell Signal 24: 1229-1240, 2012.
146. Yu M, Sturgill-Short G, Ganapathy P, Tawfik A, Peachey NS, and Smith SB. Age-related changes in visual function in cystathionine-beta-synthase mutant mice, a model of hyperhomocysteinemia. Exp Eye Res 96: 124-131, 2012.
147. Zhang W, Braun A, Bauman Z, Olteanu H, Madzelan P, and Banerjee R. Expression profiling of homocysteine junction enzymes in the NCI60 panel of human cancer cell lines. Cancer Res 65: 1554-1560, 2005.
148. Zhou Y, Yu J, Lei X, Wu J, Niu Q, Zhang Y, Liu H, Christen P, Gehring H, and Wu F. High-throughput tandemmicrowell assay identifies inhibitors of the hydrogen sulfide signaling pathway. Chem Commun (Camb) 49: 11782-11784, 2013.
149. Zou C-G and Banerjee R. Tumor necrosis factor-alphainduced targeted proteolysis of cystathionine beta-synthase modulates redox homeostasis. J Biol Chem 278: 16802-16808, 2003.